Florek Mareike, Schneidawind Dominik, Pierini Antonio, Baker Jeanette, Armstrong Randall, Pan Yuqiong, Leveson-Gower Dennis, Negrin Robert, Meyer Everett
Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.
Department of Medicine II, Eberhard Karls University, Tübingen, Germany.
PLoS One. 2015 Dec 22;10(12):e0145763. doi: 10.1371/journal.pone.0145763. eCollection 2015.
The adoptive transfer of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in murine models of allogeneic hematopoietic cell transplantation (HCT) has been shown to protect recipient mice from lethal acute graft-versus-host disease (GVHD) and this approach is being actively investigated in human clinical trials. Here, we examined the effects of cryopreservation on Tregs. We found that freeze and thaw of murine and human Tregs is associated with reduced expression of L-selectin (CD62L), which was previously established to be an important factor that contributes to the in vivo protective effects of Tregs. Frozen and thawed murine Tregs showed a reduced capacity to bind to the CD62L binding partner MADCAM1 in vitro as well as an impaired homing to secondary lymphoid organs in vivo. Upon adoptive transfer frozen and thawed Tregs failed to protect against lethal GVHD compared with fresh Tregs in a murine model of allogeneic HCT across major histocompatibility barriers. In summary, the direct administration of adoptively transferred frozen and thawed Tregs adversely affects their immunosuppressive potential which is an important factor to consider in the clinical implementation of Treg immunotherapies.
在异基因造血细胞移植(HCT)小鼠模型中,过继转移CD4+CD25+Foxp3+调节性T细胞(Tregs)已被证明可保护受体小鼠免受致死性急性移植物抗宿主病(GVHD)的影响,并且这种方法正在人类临床试验中积极研究。在此,我们研究了冷冻保存对Tregs的影响。我们发现,小鼠和人类Tregs的冻融与L-选择素(CD62L)表达降低有关,而CD62L先前已被确定为有助于Tregs体内保护作用的重要因素。冻融后的小鼠Tregs在体外与CD62L结合伴侣黏膜地址素细胞黏附分子1(MADCAM1)的结合能力降低,在体内归巢至次级淋巴器官的能力也受损。在主要组织相容性屏障的异基因HCT小鼠模型中,与新鲜Tregs相比,过继转移冻融后的Tregs在过继转移后未能预防致死性GVHD。总之,直接给予过继转移的冻融Tregs会对其免疫抑制潜能产生不利影响,这是Treg免疫疗法临床应用中需要考虑的一个重要因素。